高级检索
当前位置: 首页 > 详情页

Molecular mechanisms of glucocorticoid resistance

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]The Fourth Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, China.
出处:
ISSN:

关键词: glucocorticoid receptor glucocorticoid resistance molecular NR3C1 gene review

摘要:
As a powerful anti-inflammatory, immunosuppressive, and antiproliferative drug, glucocorticoid (GC) plays an important role in the treatment of various diseases. However, some patients may experience glucocorticoid resistance (GCR) in clinical, and its molecular mechanism have not been determined.The authors performed a review of the literature on GCR focusing on mutations in the NR3C1 gene and impaired glucocorticoid receptor (GR) signalling, using METSTR (2000 through May 2022) to identify original articles and reviews on this topic. The search terms included 'glucocorticoid resistance/insensitive', 'steroid resistance/insensitive', 'NR3C1', and 'glucocorticoid receptor'.Primary GCR is mainly caused by NR3C1 gene mutation, and 31 NR3C1 gene mutations have been reported so far. Secondary GCR is caused by impaired GC signalling pathways, including decreased expression of GR, impaired nuclear translocation of GR, and impaired binding of GR to GC and GR to target genes. However, the current research is more on the expression level of GR, and there are relatively few studies on other mechanisms. In addition, methods for improving GC sensitivity are rarely reported.The molecular mechanisms of GCR are complex and may differ in different diseases or different patients. In future studies, when exploring the mechanism of GCR, methods to improve GC sensitivity should also be investigated.© 2022 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科 3 区 医学:研究与实验
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 医学:内科 3 区 医学:研究与实验
JCR分区:
出版当年[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2024]版:
Q1 MEDICINE, GENERAL & INTERNAL Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]The Fourth Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, China.
通讯作者:
通讯机构: [1]The Fourth Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, China. [*1]The Fourth Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42313 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号